These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22757775)

  • 1. Platelet inhibition and bleeding complications in patients with haemophilia/von Willebrand's disease and coronary artery disease.
    Alesci S; Krekeler S; Seifried E; Miesbach W
    Haemophilia; 2012 Sep; 18(5):e364-5. PubMed ID: 22757775
    [No Abstract]   [Full Text] [Related]  

  • 2. Antithrombotic therapy management in patients with inherited bleeding disorders and coronary artery disease: A single-centre experience.
    Piel-Julian ML; Thiercelin-Legrand MF; Moulis G; Voisin S; Claeyssens S; Sailler L
    Haemophilia; 2020 Mar; 26(2):e34-e37. PubMed ID: 31846115
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemophilia.
    Pfaff JA; Geninatti M
    Emerg Med Clin North Am; 1993 May; 11(2):337-63. PubMed ID: 8491110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mild bleeding disorders: review of 120 patients.
    Bolton-Maggs P; Wilkinson LS
    Clin Lab Haematol; 1984; 6(3):247-56. PubMed ID: 6335071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [von Willebrand's disease and coronary atherosclerosis. Apropos of 3 cases].
    Dulhoste MN; Bonnet J; Vergnes C; Choussat A; Bricaud H
    Arch Mal Coeur Vaiss; 1989 Nov; 82(11):1875-8. PubMed ID: 2514640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-existence of von Willebrand's disease and haemophilia A.
    Cumming AM; Armstrong JG; Burn AM; Wensley RT
    Clin Lab Haematol; 1992; 14(1):91-2. PubMed ID: 1350952
    [No Abstract]   [Full Text] [Related]  

  • 7. Do patients with haemophilia and von Willebrand disease with arterial hypertension have bleeding complications: a German single centre cohort.
    Alesci RS; Krekeler S; Seifried E; Miesbach W
    Blood Coagul Fibrinolysis; 2012 Jun; 23(4):320-3. PubMed ID: 22473050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
    Majumdar G; Phillips JK; Lavallee H; Savidge GF
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):1035-7. PubMed ID: 8148477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous administration of deamino-D-arginine-vasopressin (DDAVP) to patients with hemophilia A and von Willebrand's disease].
    Janczarski M; Ruszkowska I; Cetnarowicz H; Lopaciuk S
    Acta Haematol Pol; 1990; 21(1):16-21. PubMed ID: 2260405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention in a patient with von Willebrand's disease presenting with an acute coronary syndrome.
    Macdonald J; Srinivasan M; More R
    J Invasive Cardiol; 2006 Apr; 18(4):174-7. PubMed ID: 16732061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Iatrogenic disease in hemophilia and Von Willebrand's disease].
    Bello A; Dorantes S; Loperena L; Márquez JL; Fernández E
    Bol Med Hosp Infant Mex; 1982 Jan; 39(1):23-8. PubMed ID: 6978721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications After TKA in Patients With Hemophilia or Von Willebrand's Disease.
    Cancienne JM; Werner BC; Browne JA
    J Arthroplasty; 2015 Dec; 30(12):2285-9. PubMed ID: 26143236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [sports by children with a bleeding tendency].
    van Oostrom CG
    Tijdschr Kindergeneeskd; 1990 Aug; 58(4):128-31. PubMed ID: 2219095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inhibitor to factor VIII:C in a patient with possible combined haemophilia A and von Willebrand's disease.
    Taylor LD; Dean FL; Tiedemann K; Ekert H
    Thromb Haemost; 1986 Apr; 55(2):158-61. PubMed ID: 3087000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand disease within the collective of haemophilic patients as reason for unexpected bleeding episodes.
    Siegmund B; Richter H; Pollmann H
    Haemophilia; 2007 Jan; 13(1):21-5. PubMed ID: 17212720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet function testing and risk of bleeding complications.
    Ferreiro JL; Sibbing D; Angiolillo DJ
    Thromb Haemost; 2010 Jun; 103(6):1128-35. PubMed ID: 20352168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and present status of concentrate therapy for hemophilia and von Willebrand's disease.
    Brinkhous KM
    Wien Klin Wochenschr; 1982 Oct; 94(19):509-14. PubMed ID: 6818773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuraxial techniques in obstetric and non-obstetric patients with common bleeding diatheses.
    Choi S; Brull R
    Anesth Analg; 2009 Aug; 109(2):648-60. PubMed ID: 19608843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-type von Willebrand's disease.
    Miller JL
    Clin Lab Med; 1984 Jun; 4(2):319-31. PubMed ID: 6437734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.